Coral Laboratories Ltd
Coral Laboratories Ltd (CORALAB) last traded at ₹640, a market capitalisation of ₹229 crore, on a P/E of 12.0. Over the past 52 weeks the stock has ranged between ₹360 and ₹679. Coral Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹29.62 crore and net profit of ₹5.39 crore. Coral Laboratories Ltd’s annual general meeting is scheduled for 29 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Coral Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Coral Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹29.62 cr, up 57.4% from ₹18.82 cr a year earlier. Net profit was ₹5.39 cr, up 110.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 32.23 | 22.99 | 28.13 | 18.82 | 19.03 | 21.56 | 26.48 | 29.62 |
| Expenses | 25.72 | 16.67 | 25.44 | 16.64 | 14.09 | 19.67 | 20.28 | 24.13 |
| Operating profit | 6.51 | 6.32 | 2.69 | 2.18 | 4.94 | 1.89 | 6.2 | 5.49 |
| OPM % | 20.20% | 27.49% | 9.56% | 11.58% | 25.96% | 8.77% | 23.41% | 18.53% |
| Other income | 2.54 | 2.52 | 1.71 | 2.05 | 3.03 | 2.49 | 2.64 | 2.15 |
| Interest | 0.01 | 0.02 | 0.04 | 0.06 | 0.1 | 0 | 0.01 | 0.03 |
| Depreciation | 0.51 | 0.5 | 0.51 | 0.45 | 0.45 | 0.69 | 0.54 | 0.66 |
| Profit before tax | 8.53 | 8.32 | 3.85 | 3.72 | 7.42 | 3.69 | 8.29 | 6.95 |
| Tax % | 25.21% | 26.08% | 26.49% | 31.18% | 21.56% | 24.93% | 36.91% | 22.45% |
| Net profit | 6.38 | 6.14 | 2.83 | 2.56 | 5.82 | 2.78 | 5.22 | 5.39 |
| EPS (₹) | 17.86 | 17.19 | 7.92 | 7.17 | 16.29 | 7.78 | 14.61 | 15.09 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Coral Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 97 | 76 | 78 | 84 | 115 | 86 | 97 |
| Operating profit | 16 | 8 | 4 | 16 | 26 | 15 | 19 |
| OPM % | 16% | 11% | 4.9% | 19% | 23% | 18% | 19% |
| Net profit | 14 | 9 | 6 | 16 | 24 | 16 | 19 |
| EPS (₹) | 37.93 | 25.33 | 18.05 | 44.20 | 67.63 | 45.85 | 53.77 |
TTM is the trailing twelve months to the most recent quarter.
Coral Laboratories Ltd growth and returns
- 10 Years
- 1%
- 5 Years
- -2%
- 3 Years
- 3%
- TTM
- -5%
- 10 Years
- 3%
- 5 Years
- 4%
- 3 Years
- 36%
- TTM
- 3%
- 10 Years
- 3%
- 5 Years
- 10%
- 3 Years
- 35%
- 1 Year
- 39%
- 10 Years
- 9%
- 5 Years
- 8%
- 3 Years
- 10%
- Last Year
- 8%
Coral Laboratories Ltd shareholding pattern
Promoters held 71.51% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 28.50% | 28.49% | 28.49% | 28.50% | 28.49% | 28.48% | 28.49% | 28.49% |
| No. of shareholders | 3,949 | 4,054 | 4,105 | 4,213 | 4,286 | 4,208 | 4,084 | 3,873 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Coral Laboratories Ltd’s AGM?
Coral Laboratories Ltd’s annual general meeting is scheduled for 29 Sept 2026.
- AGM44th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Coral Laboratories Ltd corporate filings
- Notice of Book ClosureCorp. Actionlow impact
Cruxal's analysis: Coral Laboratories Ltd has issued a notice regarding the closure of its Register of…
Read the full analysis - Intimation for holding 44th AGMAGM/EGMlow impact
Cruxal's analysis: Coral Laboratories Limited has formally announced the convening of its 44th Annual…
Read the full analysis - Record date for final dividend and Book Closure dateCorp. Actionlow impact
Cruxal's analysis: Coral Laboratories Limited has scheduled its 44th Annual General Meeting for September…
Read the full analysis - Outcome of Board meetingBoard Meetinghigh impact
Cruxal's analysis: Coral Laboratories Limited delivered robust financial results for the quarter ended June…
Read the full analysis - Newspaper publication on shares to be transferred to IEPFCompany Updatelow impact
Cruxal's analysis: Coral Laboratories Ltd has published a notice in newspapers concerning the mandatory…
Read the full analysis - Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. Standalone unaudited ....Board Meetinglow impact
Cruxal's analysis: Coral Laboratories Limited has issued a formal intimation regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Coral Laboratories Ltd
Cruxal reads every Coral Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.